TCA
CVS icon

Trifecta Capital Advisors’s CVS Health CVS Stock Holding History

Trifecta Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,500
Closed -$120K – 422
2024
Q1 		$120K Sell
1,500
-11
-0.7% -$840 0.03% 104
2023
Q4 		$119K Sell
1,511
-57
-4% -$4.06K 0.03% 98
2023
Q3 		$109K Buy
1,568
+25
+2% +$1.77K 0.04% 99
2023
Q2 		$107K Buy
1,543
+11
+0.7% +$783 0.03% 105
2023
Q1 		$114K Buy
1,532
+1,500
+4,688% +$126K 0.04% 104
2022
Q4 		$2.98K Buy
+32
New +$3.09K ﹤0.01% 259

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Trifecta Capital Advisors's CVS Position: Q2 2024 in Review

Trifecta Capital Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 1,500 shares — an estimated $120K sold.

Trifecta Capital Advisors first reported a position in CVS in Q4 2022 and held it in 6 quarters. The position peaked at $120K in Q1 2024. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Trifecta Capital Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Trifecta Capital Advisors sold 1,500 CVS Health shares in Q2 2024, an estimated $120K.
  • Trifecta Capital Advisors first reported a position in CVS Health in Q4 2022 and held it in 6 quarters.
  • Trifecta Capital Advisors's CVS Health position peaked at $120K in Q1 2024.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Trifecta Capital Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.